Executivul a adoptat memorandumul pentru semnarea celui de-al patrulea formular de comandă de vaccin împotriva COVID-19 produs de alianţa BioNTech/Pfizer, pentru o cantitate de 4,2 milioane de doze opţionale, 300.000 dintre acestea urmând să ajungă în România din trimestrul al II-lea al acestui an, a anunţat, joi, premierul Florin Cîţu.
:format(webp):quality(92)/https://www.economica.net/wp-content/uploads/2021/03/florin-citu-1-1620x1080-1-747x420.jpg)
:format(webp):quality(92)/https://www.economica.net/wp-content/uploads/2020/12/pfizer_biontech_covid_19_vaccine_2020_c_cropped_09724400-326x420.jpg)
:format(webp):quality(92)/https://www.economica.net/wp-content/uploads/2020/12/epiktjjwmacd4ty_67395300-560x420.jpg)
:format(webp):quality(92)/https://www.economica.net/wp-content/uploads/2016/11/635930169391079250_wall_street_3_7_16_doweraselosses_26437100.JPG)
:format(webp):quality(92)/https://www.economica.net/wp-content/uploads/2020/02/wall_street_sign_1475134755nbn_39882700.jpg)
:format(webp):quality(92)/https://www.economica.net/wp-content/uploads/2020/07/vaccin_7658490685940_08042100.jpg)
:format(webp):quality(92)/https://www.economica.net/wp-content/uploads/2020/05/cdu_parteitag_dezember_2012_von_der_leyen_06951500-627x420.jpg)
